RESUMEN

The essential oils prepared by hydrodistillation of twenty-one brands of German chamomile (S1-S21) commercialized in Mexico were analyzed by GS-MS. Altogether, twenty-four different compounds were identified in the analyzed samples, varying from 77 to 100 % of the total composition. Multivariate analyses were applied to explore similarity/dissimilarity and correlation between all samples; the results revealed a strong correlation among samples S4, S5, and S7-S21 due to the presence of (Z)-en-yn-dicycloether [(Z)-tonghaosu], α-bisabolol, ß-farnesene, ß-eudesmol, and xanthoxylin. The samples S1-S3 and S6 were clustered separately. Samples S1, S3, and S6 were characterized by their higher content of bisabolol oxide A (38.78 %, 51.84 %, and 70.46 %, respectively) as most known chemotypes of German chamomile, but only S1 and S3 contained chamazulene. Finally, S2 differed from the others because of its high content of (E)-anethole (62.28 %), suggesting a case of adulteration or substitution of the crude drug employed for manufacturing the product.

Asunto(s)

Cromatografía de Gases y Espectrometría de Masas , Matricaria , Aceites Volátiles , Aceites Volátiles/química , México , Matricaria/química , Sesquiterpenos/química , Sesquiterpenos/análisis , Sesquiterpenos Monocíclicos/química , Derivados de Alilbenceno/química

RESUMEN

OBJECTIVE: The search for treatments that accelerate the healing of lesions is of constant interest. Matricaria recutita (chamomile) is a plant with antimicrobial, anti-inflammatory, and healing properties, and antimicrobial Photodynamic Therapy (aPDT) eradicates microorganisms, which favors tissue repair. This study aimed to evaluate the effect of the topical use of chamomile with or without aPDT on tissue repair in rats' tongues. METHODOLOGY: A total of 75 male Wistar rats underwent standardized ulceration on the dorsum of the tongue using a punch of 5 mm diameter and were randomly allocated into the following groups: control (G1), chamomile fluid extract (G2), chamomile infusion (G3), aPDT (G4), and chamomile infusion + aPDT (G5). On the 3rd, 7th, and 14th days postoperatively, euthanasia was performed, and the ulcers were measured using calipers. The presence of edema, inflammatory infiltrate, cellularity, re-epithelialization, and characterization of total collagen were evaluated using sections stained with Hematoxylin and Eosin and Red Sirius. Histomorphometry analyses of the percentage of total collagen, the distance from the basal layer to the epithelial surface, and the thickness of the stratum corneum were performed. Descriptive (absolute/relative frequencies and modes) and exploratory analyses were performed. The associations between the groups and the presence of ulcers were analyzed with Fisher's exact test. All analyses were performed using the R program and statistical significance was set at p=0.05. RESULTS: The G2 positively modulated the exudative and proliferative phases of repair, both clinically (p<0.0001) and histologically, whether in descriptive or inferential analyses (p<0.05). The G3 showed a significant difference in clinical parameters compared with G1 (p<0.0001). The G4 and G5 did not positively modulate tissue repair. CONCLUSION: The chamomile fluid extract showed better outcomes for tissue repair in the rat tongue.

Asunto(s)

Antiinfecciosos , Matricaria , Fotoquimioterapia , Ratas , Animales , Ratas Wistar , Úlcera/tratamiento farmacológico , Extractos Vegetales/farmacología , Colágeno , Antiinfecciosos/uso terapéutico , Lengua

Asunto(s)

COVID-19 , Matricaria , Humanos , Perú/epidemiología , COVID-19/epidemiología

RESUMEN

AIM: To evaluate in vitro the antibacterial efficacy of Matricaria recutita (chamomile) essential oil at 50 and 75% against Porphyromonas gingivalis ATCC 33277 and Prevotella intermedia ATCC 25611 at 24 and 48 hours. MATERIAL AND METHODS: The sample consisted of 80 discs and Mueller-Hinton Agar, the medium chosen for the culture. To determine the bacterial sensitivity, discs were placed in each Petri dish with concentrations of essential oil at 50 and 75%, distilled water and 0.12% chlorhexidine. Subsequently, the inhibition halos were measured in millimeters at 24 and 48 hours after culture, with the Kirby-Bauer disk diffusion method. RESULTS: In groups treated with Porphyromonas gingivalis, measurements at 24 and 48 hours yielded 22.14 ± 2.61 and 22.63 ± 2.67 mm for 0.12% chlorhexidine, 18.90 ± 0.41 and 19.22 ± 0.54 mm for 75% essential oil, and 15.55 ± 0.45 and 15.77 ± 0.46 mm for 50% essential oil, respectively. No statistically significant differences were observed among the groups (p > 0.05). CONCLUSION: No significant differences were found between the antibacterial efficacy of 0.12% chlorhexidine and 50 and 75% essential oil of Matricaria recutita on Porphyromonas gingivalis and Prevotella intermedia at 24 and 48 hours. CLINICAL SIGNIFICANCE: The study demonstrates that essential oil derived from Matricaria recutita may effectively combat bacteria associated with periodontal disease. This discovery has the potential to impact dental practice by introducing a natural treatment option. Further research is warranted to fully elucidate the clinical significance and potential applications of this finding.

Asunto(s)

Matricaria , Aceites Volátiles , Porphyromonas gingivalis , Aceites Volátiles/farmacología , Prevotella intermedia , Clorhexidina , Antibacterianos/farmacología

RESUMEN

A depressão é uma doença grave que atinge a população em geral, estudos epidemiológicos estimam que a prevalência da depressão ao longo da vida no Brasil está em torno de 15,5%. Os fatores que desencadeiam o aparecimento da depressão incluem fatores sociais, psicológicos, biológicos e também fatores externos específicos como eventos estressantes, solidão, consumo de álcool e drogas, doenças crônicas e dar á luz (depressão pós-parto). O objetivo da presente pesquisa consistiu em realizar uma revisão bibliográfica sobre as principais plantas medicinais com ação antidepressiva. A ansiedade vem se tornando um dos principais problemas da atualidade, sendo intensificada pela pandemia causada pelo coronavírus, onde constatou-se que durante o pico da pandemia onde os casos confirmados de COVID-19 no Brasil ascenderam de 45.757 para 330.890, e as mortes, de 2.906 para 21.048, o sentimento de tristeza/depressão atingiu 40% dos adultos brasileiros. Os sintomas de depressão podem ser amenizados quando a disponibilidade sináptica de monoaminas são aumentadas, e esse aumento pode ocorrer através da diminuição da metabolização desses neurotransmissores. Neste sentido, busca-se através da farmacoterapia a utilização de antidepressivos que disponibilizem as monoaminas na fenda sináptica. A escolha do fármaco é feita com base nos sintomas da depressão e na boa resposta a uma determinada classe de antidepressivos. Em fevereiro de 2009 o Ministério da saúde lançou a Relação Nacional de Plantas Medicinais de Interesse ao SUS (RENISUS), contendo 71 espécies vegetais que são distribuídas de forma in natura nas unidades básicas de saúde (UBS). Destas, somente três espécies apresentam efeito antidepressivo e ansiolítico comprovados na literatura sendo Matricharia chamomilla, Erytrinum mulungu e a Passiflora incarnata que também fazem parte da RENISUS. Além destas, outras espécies como a Melissa officinalis, Lippia alba, Valeriana officinalis e Piper methysticum são utilizadas pela população para tratar ansiedade, insônia e depressão, sugerindo desta forma que estas espécies sejam incluídas na RENISUS.

---

Depression is a serious disease that affects the general population, epidemiological studies estimate that the prevalence of depression throughout life in Brazil is around 15.5%. The factors that trigger the onset of depression include social, psychological, biological and also specific external factors such as stressful events, loneliness, alcohol and drug consumption, chronic diseases and giving birth (postpartum depression). The objective of the present research was to carry out a literature review on the main medicinal plants with antidepressant action. Anxiety has become one of the main problems of today, being intensified by the pandemic caused by the coronavirus, where it was found that during the peak of the pandemic where confirmed cases of COVID-19 in Brazil rose from 45,757 to 330,890, and deaths, from 2,906 to 21,048, the feeling of sadness/depression reached 40% of Brazilian adults. Symptoms of depression can be alleviated when synaptic availability of monoamines is increased, and this increase can occur through decreased metabolization of these neurotransmitters. In this sense, the use of antidepressants that make monoamines available in the synaptic cleft is sought through pharmacotherapy. The choice of drug is based on symptoms of depression and good response to a particular class of antidepressants. In February 2009, the Ministry of Health launched the National List of Medicinal Plants of Interest to the SUS (RENISUS), containing 71 plant species that are distributed in natura form in basic health units (UBS). Of these, only three species have antidepressant and anxiolytic effects proven in the literature, being Matricharia chamomilla, Erytrinum mulungu and Passiflora incarnata, which are also part of RENISUS. In addition to these, other species such as Melissa officinalis, Lippia alba, Valeriana officinalis and Piper methysticum are used by the population to treat anxiety, insomnia and depression, thus suggesting that these species are included in RENISUS.

---

Los estudios epidemiológicos estiman que la prevalencia de la depresión a lo largo de la vida en Brasil es de alrededor del 15,5%. Los factores que desencadenan la aparición de la depresión son sociales, psicológicos, biológicos y también factores externos específicos, como los acontecimientos estresantes, la soledad, el consumo de alcohol y drogas, las enfermedades crónicas y el parto (depresión posparto). El objetivo de esta investigación fue realizar una revisión bibliográfica sobre las principales plantas medicinales con acción antidepresiva. La ansiedad se ha convertido en uno de los principales problemas de la actualidad, intensificándose por la pandemia causada por el coronavirus, donde se encontró que durante el pico de la pandemia donde los casos confirmados de COVID-19 en Brasil aumentaron de 45.757 a 330.890, y las muertes, de 2.906 a 21.048, el sentimiento de tristeza/depresión alcanzó el 40% de los adultos brasileños. Los síntomas de la depresión pueden aliviarse cuando se aumenta la disponibilidad sináptica de las monoaminas, y este aumento puede producirse mediante una disminución de la metabolización de estos neurotransmisores. En este sentido, se busca a través de la farmacoterapia el uso de antidepresivos que hagan disponibles las monoaminas en la hendidura sináptica. La elección del fármaco se hace en función de los síntomas de la depresión y de la buena respuesta a una clase concreta de antidepresivos. En febrero de 2009, el Ministerio de Salud lanzó la Lista Nacional de Plantas Medicinales de Interés para el SUS (RENISUS), que contiene 71 especies de plantas que se distribuyen in natura en unidades básicas de salud (UBS). De ellas, sólo tres especies tienen efectos antidepresivos y ansiolíticos probados en la literatura: Matricharia chamomilla, Erytrinum mulungu y Passiflora incarnata, que también forman parte del RENISUS. Además de éstas, otras especies como Melissa officinalis, Lippia alba, Valeriana officinalis y Piper methysticum son utilizadas por la población para tratar la ansiedad, el insomnio y la depresión, lo que sugiere que estas especies se incluyan en el RENISUS.

Asunto(s)

Plantas Medicinales/efectos de los fármacos , Sistema Único de Salud , Sistema Nervioso Central/efectos de los fármacos , Ansiedad/tratamiento farmacológico , Ansiolíticos/uso terapéutico , Valeriana/efectos de los fármacos , Preparaciones Farmacéuticas , Kava/efectos de los fármacos , Passiflora/efectos de los fármacos , Matricaria/efectos de los fármacos , Melissa/efectos de los fármacos , Lippia/efectos de los fármacos , Depresión/tratamiento farmacológico , Quimioterapia , Emociones/efectos de los fármacos , Erythrina/efectos de los fármacos , Pandemias/prevención & control , Antidepresivos/uso terapéutico

RESUMEN

The objective of this study was to evaluate the effect of topical chamomile in the prevention and/or treatment of oral mucositis (OM) in cancer patients. It was a systematic review, which sought articles of the randomized clinical trial according to the PRISMA parameters, registered in the PROSPERO. The databases used were PubMed, Cochrane Library, and Bireme. Descriptors were selected from DeCs/MeSH and the PICO strategy was applied. The search found 148 publications. After all the steps, six articles were selected. The total sample included 492 patients and all studies used the same OM measurement scale. The results showed that the application of topical chamomile was effective in the prevention and/or treatment of OM in four of the six studies, with a dose ranging from 1% to 2.5% and duration that ranged from single to 4 times a day. Some limitations were observed: the minimum age of the patients was not informed, and there was no specification of the sites involved or the chemotherapies used. The application of topical chamomile in the preventive/therapeutic of chemo-induced OM seems to be recommended. In addition, scientific production should be encouraged, as it aims to determine useful protocols for this phytotherapy for the oncology population.

Asunto(s)

Matricaria , Estomatitis , Manzanilla , Quimioradioterapia , Humanos , Extractos Vegetales/farmacología , Ensayos Clínicos Controlados Aleatorios como Asunto , Estomatitis/inducido químicamente , Estomatitis/tratamiento farmacológico

RESUMEN

This study aimed to determine if the homeopathic formulation based on Natrum muriaticum, Matricaria, Chamomilla, and Ignatia amara was effective for stress control in dogs in order to prevent and/or reduce the frequency of unwanted behaviors. Ten male beagle dogs were divided into two groups, with five animals per group. The control group was animals receiving 0.5 mL/day of placebo via spray in the feed for 30 consecutive days as a preventive. The treated group received 0.5 mL/day of tested drug spray in the feed for 30 consecutive days as a preventive. Behavioral tests were performed at two time points, before and after receiving the tested drug. We performed the following behavioral tests: a) persons known and unknown in the internal and external environment; b) interaction with toys; c) interaction with an unknown dog, d) test with a leash; and e) firecracker test. There was more engagement in digging and scaling the fence in the control group than in the treatment group (P < 0.05). The animals that received homeopathic medicine sat 2.54 times longer than the control (P = 0.0269). Dogs that received homeopathic showed 4.49 times more interest in general at D30 than at D1 (P = 0.0214). Animals in the treated group showed an 83% less chance of urinating than the control group in the tests involving displacements. We conclude that the preventive addition of homeopathic medicine containing Natrum muriaticum, Chamomilla, and Ignatia amara reduced undesirable behaviors related to anxiety and increased the incidence of interest behavior.(AU)

---

Este estudo visou determinar se a formulação homeopática baseada em Natrum muriaticum, Matricaria, Chamomilla, e Ignatia amara foi eficaz para o controle de stress em cães, a fim de prevenir e/ou reduzir a frequência de comportamentos indesejados. Dez cães beagle machos foram divididos em dois grupos, com cinco animais por grupo. O grupo controle recebeu 0,5 mL/dia de placebo via spray na ração durante 30 dias consecutivos, como preventivo. O grupo tratado recebeu 0,5 mL/dia de homeopático via spray na ração durante 30 dias consecutivos, como preventivo. Os testes comportamentais foram realiza-dos em dois momentos, antes e depois de receber o fármaco testado. Foram realizados os seguintes testes comportamentais: a) pessoas conhecidas e desconhecidas no ambiente interno e externo; b) interação com brinquedos; c) interação com um cão desconhecido, d) teste com a guia; e teste com fogos de artifício. Houve um aumento nos comportamentos cavar e escalar a grade no controle (P < 0,05). Os animais que receberam o homeopático sentaram-se 2,54 vezes mais do que o grupo con-trole (P = 0,0269). Os cães que receberam homeopático mostraram 4,49 vezes mais interesse em geral no D30 do que no D1 (P = 0,0214). Os animais do grupo tratado mostraram uma probabilidade 83% menor de urinar do que o grupo controle nos testes envolvendo deslocamento. Concluímos que a adição preventiva de medicamentos homeopáticos contendo Natrum muriaticum, Chamomilla, e Ignatia amara reduziu os comportamentos indesejáveis relacionados com a ansiedade e aumentou a incidência de comportamentos de interesse.(AU)

Asunto(s)

Animales , Conducta Animal/efectos de los fármacos , Perros/fisiología , Dietoterapia Homeopática , Fenómenos Fisiológicos Nutricionales de los Animales/fisiología , Chamomilla/efectos adversos , Ignatia amara/efectos adversos , Natrium Muriaticum/efectos adversos , Matricaria/efectos adversos

RESUMEN

This study evaluated the effect of experimental solutions containing plant extracts on bacterial species and enamel caries prevention. Microcosm biofilm was produced from human saliva mixed with McBain saliva (0.2% sucrose) on bovine enamel for 5 days (3 days under anaerobiosis and 2 days under aerobiosis) at 37°C. From the 2nd day, the following treatments were applied (1 × 60 s/day): Vochysia tucanorum (10 mg/mL); Myrcia bella (5 mg/mL); Matricaria chamomilla (80 mg/mL); Malva sylvestris, fluoride, and xylitol (Malvatricin Plus®); 0.12% chlorhexidine (CHX, PerioGard®); and PBS (negative control). The medium pH was measured. Quantitative polymerase chain reaction was performed for the detection of Streptococcus mutans and Lactobacillus spp. Enamel demineralization was measured by spectral-domain optical coherence tomography. The data were compared by means of the Kruskal-Wallis/Dunn, two-way ANOVA/Bonferroni, and ANOVA/Tukey tests (p < 0.05). The pH decreased after sucrose exposure; only CHX reestablished pH >5.5 by the last day. CHX also eliminated Lactobacillusspp., but the other treatments did not differ significantly from PBS. Malvatricin Plus® and CHX eliminated S. mutans, but the other treatments did not differ from PBS. Similar results were seen concerning the reduction of lesion depth and reflectivity. The experimental natural-extract solutions were ineffective against cariogenic bacteria and in preventing the development of enamel caries.

Asunto(s)

Caries Dental , Malva , Matricaria , Desmineralización Dental , Animales , Biopelículas , Bovinos , Caries Dental/prevención & control , Susceptibilidad a Caries Dentarias , Humanos , Extractos Vegetales/farmacología , Streptococcus mutans

RESUMEN

OBJECTIVES: This systematic review evaluated the effect of phytotherapeutics in the treatment and prevention of 5-fluorouracil (5-FU)-induced oral mucositis (OM) in animal models. DESIGN: A search was performed in PubMed/Medline, CENTRAL (The Cochrane Library), EMBASE, and Web of Science, including studies published up to January 2020. Only articles investigating the chemoinduction of OM by 5-FU in animal models were included. Eligibility was evaluated and data were extracted from the eligible studies following the predefined PICO questions. The Cochrane Collaboration Risk of Bias Assessment tool was used to evaluate the quality of the included studies. RESULT: A total of 503 articles were retrieved and 13 were included. The hamster was the animal model used in all included studies. The treatment method ranged from the topical application of ointment (n = 3), gel (n = 5) and extract (n = 3) to the oral ingestion of the phytotherapeutics (n = 3). Chamomilla recutita L. (n = 3) and Pistacia atlantica (n = 3) were the most used therapeutic agents. Although all studies were classified as high risk of bias, all of them reported promising results regarding the use of phytotherapeutics in the management of OM, including lower clinical and histopathological scores as well as healing, anti-inflammatory, antimicrobial, and antioxidant activities. CONCLUSION: Despite the high risk of bias of the studies, phytotherapy is a promising alternative for the treatment of 5-FU-induced OM, showing interesting results in terms of tissue healing and anti-inflammatory, antimicrobial and antioxidant activity.

Asunto(s)

Fitoterapia , Preparaciones de Plantas/uso terapéutico , Estomatitis/tratamiento farmacológico , Animales , Antiinfecciosos/uso terapéutico , Antiinflamatorios/uso terapéutico , Antioxidantes/uso terapéutico , Cricetinae , Fluorouracilo/efectos adversos , Matricaria/química , Pistacia/química , Estomatitis/inducido químicamente , Estomatitis/prevención & control

RESUMEN

Objectives: To evaluate (1) the effect of a salivary substitute prepared using chamomile (Matricaria chamomilla L.) flower and flax (Linum usitatissimum L.) seed to relieve Primary burning mouth syndrome (BMS) symptoms, (2) their effect on the inhibition of matrix metallopeptidase 2 (MMP2) and MMP9 metalloproteinases, and (3) their potential cellular cytotoxic effect. Subjects: 40 women aging >40 years with diagnosis of primary BMS. Settings/Location: Center of Diagnosis of Diseases of the Mouth, Federal University of Pelotas, Brazil. Design: This was an open clinical trial where primary BMS patients used the homemade salivary. At the first appointment, after 30 and 60 days, the authors evaluated the pattern and intensity of BMS and xerostomia symptoms, and then determined and compared the unstimulated salivary flow rate (SFR), viscosity, and salivary pH. MMP2 and MMP9 activities in saliva and cytotoxicity were assessed using different concentrations of chamomile flower and flax seed separately. Interventions: Subjects used the homemade salivary substitute for 3 months and were instructed to rinse their mouth three to four times daily for 1 min. Outcome measures: A numeric rating scale to evaluate the intensity of burning sensation and xerostomia symptoms, salivary flow rate (SFR) to determine salivary volume, dynamic rheology technique for viscosity and a digital meter for salivary pH. MMP2 and MMP9 activities in saliva and cytotoxicity were assessed by zymography and cell viability assay respectively. Results: After treatment, severity of BMS symptoms decreased, the SFR increased, salivary viscosity decreased, and severity of xerostomia sensation (in patients who reported having this symptom) improved (p < 0.05). Chamomile flower and flax seed had no effect on inhibiting MMP2 and MMP9 activities, and neither showed cellular cytotoxic effects. Conclusion: This homemade salivary substitute is an economical, viable, easily manipulated, noncytotoxic, and a practical alternative to relieve BMS symptoms.

Asunto(s)

Síndrome de Boca Ardiente/terapia , Manzanilla , Lino , Matricaria , Extractos Vegetales/uso terapéutico , Saliva , Xerostomía/terapia , Anciano , Anciano de 80 o más Años , Femenino , Flores , Humanos , Persona de Mediana Edad , Boca/efectos de los fármacos , Boca/patología , Fitoterapia , Extractos Vegetales/farmacología , Semillas

RESUMEN

Matricaria chamomilla L. has been used for centuries in many applications, including antiparasitic activity. Leishmaniasis is a parasitic disease, with limited treatments, due to high cost and toxicity. Thus, there is a need to develop new treatments, and in this context, natural products are targets of these researches. We report the development of chitosan nanocapsules containing essential oil of M. chamomilla (CEO) from oil-in-water emulsions using chitosan modified with tetradecyl chains as biocompatible shell material. The nanocapsules of CEO (NCEO) were analyzed by optical microscopy and dynamic light scattering, which revealed spherical shape and an average size of 800 nm. Successful encapsulation of CEO was further confirmed by fluorescence microscopy observations taking advantage of the autofluorescence properties of CEO. The encapsulation efficiency was around 90%. The entrapment of CEO reduced its cytotoxicity towards normal cells. On the other hand, the CEO was active against promastigotes and intracellular amastigotes, exhibiting IC50 of 3.33 µg/mL and 14.56 µg/mL, respectively, while NCEO showed IC50 for promastigotes of 7.18 µg/mL and for intracellular amastigotes of 14.29 µg/mL. These results demonstrate that encapsulation of CEO in nanocapsules using an alkylated chitosan biosurfactant as a "green" stabilizer is a promising therapeutic strategy to treat leishmaniasis.

Asunto(s)

Antiinfecciosos/farmacología , Quitosano/química , Leishmania/efectos de los fármacos , Leishmaniasis Cutánea/tratamiento farmacológico , Matricaria/química , Nanocápsulas/química , Aceites Volátiles/farmacología , Antiinfecciosos/química , Línea Celular , Quitosano/análogos & derivados , Quitosano/síntesis química , Portadores de Fármacos/química , Dispersión Dinámica de Luz , Humanos , Iridoides/química , Queratinocitos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Microscopía Fluorescente , Tamaño de la Partícula , Tensión Superficial

RESUMEN

OBJECTIVE: This study evaluated the antibiofilm and anti-caries effects of an experimental mouth rinse containing aqueous extract of Matricaria chamomilla L. METHODS: Microcosm biofilm was produced on bovine enamel, from pooled human saliva mixed with McBain saliva, under 0.2 % sucrose exposure, for 5 days. The biofilm was daily treated using (1 mL/1 min): Vochysia tucanorum Mart. (2.5 mg/mL); Myrcia bella Cambess. (1.25 mg/mL); Matricaria chamomilla L. (20 mg/mL); Malva sylvestris (Malvatricin® Plus-Daudt); 0.12 % Chlorhexidine (PerioGard®-Palmolive, Positive control) and PBS (Negative control). The % dead bacteria, biofilm thickness, EPS biovolume, lactic acid concentration, the CFU counting (total microorganisms, Lactobacillus sp., total streptococci and Streptococcus mutans/S. sobrinus) were determined. Enamel demineralization was measured by TMR. RESULTS: All mouth rinses induced bacterial death compared to PBS (p < 0.0001). The biofilm thickness varied from 12 ±â€¯2 µm (chlorhexidine) to 18 ±â€¯2 µm (V. tucanorum) (ANOVA/Tukey, p < 0.0001). The EPS biovolume varied from 7(4)% (chlorhexidine) to 30(20)% (PBS) (Kruskal-Wallis/Dunn, p < 0.0001). The lactic acid production was reduced by M. sylvestris (1.1 ±â€¯0.2 g/L) and chlorhexidine (0.6 ±â€¯0.2 g/L) compared to PBS (2.6 ±â€¯1.3 g/L) (ANOVA, p < 0.0001). Malva sylvestris and chlorhexidine showed significant low CFU for total microorganisms, Lactobacillus sp. and total streptococci. Only chlorhexidine significantly reduced S. mutans/S. sobrinus. CFUs for total streptococci and Lactobacillus sp, were also significantly reduced by M. chamomilla L. Malva sylvestris (63.4 % of mineral loss reduction), chlorhexidine (47.4 %) and M. chamomilla L. (39.4 %) significantly reduced enamel demineralization compared to PBS (ANOVA/Tukey, p < 0.0001). CONCLUSION: M. chamomilla L. has lower antibiofilm action, but comparable anti-caries effect to those found for chlorhexidine, under this model. CLINICAL RELEVANCE: This study shows that the antibiofilm and anti-caries potential may vary between the commercial and experimental mouth rinses containing natural agents, with promising results for those containing Matricaria chamomilla L. and Malva Sylvestris.

Asunto(s)

Caries Dental , Matricaria , Desmineralización Dental , Animales , Biopelículas , Cariostáticos , Bovinos , Clorhexidina/farmacología , Esmalte Dental , Humanos , Antisépticos Bucales/farmacología , Streptococcus mutans

RESUMEN

Matricaria chamomilla L. contains antioxidant flavonoids that can have their bioactivity enhanced by enzymatic hydrolysis of specific glycosyl groups. This study implements an untargeted metabolomics approach based on ultra-performance liquid chromatography coupled with electrospray ionisation quadrupole time-of-flight mass spectrometry technique operating in MSE mode (UPLC-QTOF-MSE) and spectrophotometric analysis of chamomile aqueous infusions, before and after hydrolysis by hesperidinase and ß-galactosidase. Several phenolic compounds were altered in the enzymatically treated infusion, with the majority being flavonoid derivatives of apigenin, esculetin, and quercetin. Although enzymatically modifying the infusion only led to a small increase in antioxidant activity (DPPH• method), its inhibitory effect on pancreatic lipase was of particular interest. The enzymatically treated infusion exhibited a greater inhibitory effect (EC50 of 35.6 µM) than unmodified infusion and kinetic analysis suggested mixed inhibition of pancreatic lipase. These results are of great relevance due to the potential of enzymatically treated functional foods in human health.

Asunto(s)

Antioxidantes/farmacología , Inhibidores Enzimáticos/farmacología , Flavonoides/farmacología , Lipasa/antagonistas & inhibidores , Matricaria/química , Antioxidantes/química , Antioxidantes/metabolismo , Compuestos de Bifenilo/antagonistas & inhibidores , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/metabolismo , Flavonoides/química , Flavonoides/metabolismo , Glicósido Hidrolasas/metabolismo , Humanos , Hidrólisis , Lipasa/metabolismo , Matricaria/metabolismo , Metabolómica , Estructura Molecular , Picratos/antagonistas & inhibidores , Relación Estructura-Actividad , beta-Galactosidasa/metabolismo

RESUMEN

Abstract Methotrexate (MTX) was shown to cause oxidative stress and liver damage. The objective was to investigate the possible protective effects of Matricaria Chamomilla L. (chamomile) extract with anti-oxidant and anti-inflammatory properties on the methotrexate-induced liver toxicity. Twenty four Wistar rats were divided into four groups. MTX group was injected intraperitoneally on days 7 and 14 with 20 mg/kg methotrexate. Groups CE200 (chamomile extract 200 mg/kg/day) and CE300 (chamomile extract 300 mg/kg/day) received the same dose of methotrexate added with chamomile extract orally for 15 days at 200 mg/kg and 300 mg/kg respectively and the last group was healthy control group. Results of biochemical analyses indicated serum liver biomarkers (aminotransferases), alkaline phosphatase (ALP), albumin, and liver content of anti-oxidant enzymes (catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px)), reduced glutathione (GSH) and total anti-oxidant capacity (TAC) significantly increased (P <0.05-0.001) to normal in the CE treated groups compared to those of the MTX group. Serum bilirubin and hepatic malondialdehyde (MDA) levels significantly increased (P ˂0.001) in MTX group compared to those of the control group and decreased in CE200 and CE300 groups compared to those of the MTX group. Histopathological study showed inflammatory damage, necrotic cells and lipid infiltration in MTX group. In the groups treated with the chamomile extract, a significant improvement was observed in liver tissue in response to increased dose of the extract. In conclusion, chamomile extract administration could have a protective role in methotrexate-induced liver toxicity in rats through improving anti-oxidant defense system.

Asunto(s)

Animales , Masculino , Ratas , Extractos Vegetales/uso terapéutico , Metotrexato/toxicidad , Sustancias Protectoras/uso terapéutico , Matricaria/química , Hígado/efectos de los fármacos , Ratas Wistar

RESUMEN

The enzyme tyrosinase is involved in the biosynthesis of melanin and the enzymatic browning of fruits and vegetables, and therefore, its inhibitors have potential to treat hyperpigmentary disorders or to function as food antibrowning agents. The use of hydrazine monohydrate as a reagent to prepare chemically engineered extracts can lead to semisynthetic compounds that contain the portion N-N, a fragment rarely found in natural products and present in some tyrosinase inhibitors. Here, we report the tyrosinase inhibition screening of a series of chemically engineered extracts that are diversified by reaction with hydrazine. LC-MS was used to evaluate the change in composition produced by the reaction. Bioguided fractionation of the most active chemically engineered extract, prepared from Matricaria recutita L., led to the discovery of a pyrazole that inhibits tyrosinase with an IC50 value of 28.20 ± 1.13 µM. This compound was produced by a one-pot double chemical transformation of its natural precursor, which includes an unexpected selective removal of one -OH group.

Asunto(s)

Inhibidores Enzimáticos/química , Hidrazinas/química , Matricaria/química , Extractos Vegetales/química , Ingeniería Química , Diseño de Fármacos , Flavonas/química , Melaninas/química , Melaninas/metabolismo , Estructura Molecular , Monofenol Monooxigenasa/antagonistas & inhibidores , Pirazoles/química , Relación Estructura-Actividad

RESUMEN

Skin diseases have a notable impact on the life of the affected and in their health conditions. In order to allow a more effective and economical treatment for such disorders, new therapeutic approaches have been continuously investigated. Due to its high therapeutic and phytochemical potential, Matricaria species emerges as a pleasant alternative, since it is an important source of bioactive secondary metabolites suitable for the treatment of varied skin diseases. Therefore, this review aimed to catalog inventions that have used Matricaria species as the active component for skin disease treatment in order to assess the status of the technological development of the fitomedicines. For this, a search of patents was performed in four specialized patent database, which have reported the discovery of pharmaceutical bioproducts that used Matricaria species in its composition for skin treatment. Therefore, it is possible to notice that the pharmaceutical industry has driven efforts and investment to produce medicines for the dermatopathies, using species of this genus as an active principle. Besides, a trend of growth has been identified for the last years, which is accompanied by the continuous publication of scientific articles on the subject. It is known that a long journey is traversed between the scientific findings and their applications in the pharmaceutical market, creating the perspective that new Matricaria-based medicines may reach the pharmaceutical market in the coming years.

Asunto(s)

Matricaria/química , Fitoterapia , Extractos Vegetales/farmacología , Enfermedades de la Piel/tratamiento farmacológico , Humanos , Patentes como Asunto , Fitoquímicos/farmacología

RESUMEN

Chamomile is one of most known species of medicinal plants. It has valuable pharmacological properties that produce positive effects in many therapeutical uses. Some of these properties are attributed to the presence of secondary metabolites but is already known that primary metabolites can also produce positive effects. In this study we elucidate the fine chemical structure of polysaccharides present in the infusion of chamomile flower chapters. After ethanolic precipitation, polysaccharides were obtained from the tea (fraction MRW, 3.2% yield), purified and characterized as an inulin type fructan, a highly methyl esterified and acetylated homogalacturonan (DE = 87% and DA = 19%), and a type II arabinogalactan. From ethanolic supernatant (20.2% yield), fructooligosaccharides (FOS) ranging from GF2 (m/z 543) to GF10 (m/z 1839) were detected. Inulin and FOS are well-established prebiotics, as well as the pectic polysaccharides. Thus, chamomile could be a source of structurally diverse dietary fibers with potential prebiotic, gastrointestinal and immunological functions.

Asunto(s)

Matricaria/química , Oligosacáridos/química , Polisacáridos/química , Flores/química , Oligosacáridos/aislamiento & purificación , Polisacáridos/aislamiento & purificación

RESUMEN

The objective of the this research was to register the current popular therapeutic use of medicinal plants in the Tzotzil indigenous population, in The Highlands of Chiapas, Mexico. The data were collected from 59 informants (39% men, 61% women) between 20 and 86 years old, through a semi-structured questionnaire in the Tzotzil language. From the information collected, a total of 59 species of medicinal plants were registered, belonging to 55 genera and 37 botanical families. The families Asteraceae (with 6 species and UR=51), Lamiaceae (4, UR=37) and Lauraceae (4, UR=21), are were the most representative in the study area. The highest use value index (UVI) was reported for Matricaria chamomilla (UVI=0.42), Mentha sativa (UVI=0.36) and Ruta graveolens (UVI=0.31). According to the informant consensus factor (ICF), the main pathological categories treated are were of the reproductive system (ICF=0.80), respiratory infections (ICF=0.75) and diseases of the digestive system (ICF=0.70). The species reported and their diversity of uses satisfy the needs of families with socioeconomic deficiencies.

---

El objetivo de la esta investigación fue registrar el uso terapéutico popular actual de plantas medicinales en la población indígena Tzotzil, en Los Altos de Chiapas, México. Los datos fueron recolectados de 59 informantes (39% hombres, 61% mujeres) entre 20 y 86 años, a través de un cuestionario semiestructurado en el idioma Tzotzil. De la información recabada, se registraron un total de 59 especies de plantas medicinales, pertenecientes a 55 géneros y 37 familias botánicas. Las familias Asteraceae (con 6 especies y RU=51), Lamiaceae (4, RU=37) y Lauraceae (4, RU=21), son fueron las más representativas en el área de estudio. El índice de valor de uso más alto (IVU) se informó para Matricaria chamomilla (IVU=0.42), Mentha sativa (IVU=0.36) y Ruta graveolens (IVU=0.31). Según el factor de consenso del informante (FCI), las principales categorías patológicas tratadas son fueron del sistema reproductivo (ICF=0.80), las infecciones respiratorias (ICF=0.75) y las enfermedades del sistema digestivo (ICF=0.70). Las especies reportadas y su diversidad de usos satisfacen las necesidades de las familias con deficiencias socioeconómicas.

Asunto(s)

Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Plantas Medicinales , Asteraceae , Medicina Tradicional , Matricaria , México

RESUMEN

OBJECTIVE: The objective of this study was to review the effects of the Matricaria recutita (L.) in the treatment of oral mucositis. METHODOLOGY: The online search was performed in the period from June 2016 to April 2018 by means of databases LILACS (Latin American and Caribbean Center on Health Sciences Information), SciELO (Scientific Electronic Library Online), and MEDLINE (Medical Literature Analysis and Retrieval System Online). The consultation was restricted to the years 1991 to 2018 with the aim of elucidating the effects of Matricaria recutita in the treatment of oral mucositis. RESULTS: The final sample consisted of 21 studies, of which 10 were developed in animals and 11 in humans, published from 1991 to 2017, with a total sample of 644 patients. The total number of patients treated with Matricaria included in 11 studies was 364, while in the control groups the total number was 280. In experimental studies, animal models used were rats and the sample size ranged between 36 and 105 animals submitted to the induction of oral mucositis, where 4 studies used an intraperitoneal injection of 5-fluorouracil, while 7 induced lesion in the mucosa. From the data collected, it should be noted that both studies with humans and with animals showed significant effects. In this way, there is strong evidence for the discussion on the therapy; however, it should be noted that more studies are developed in order to clarify the most appropriate protocol for the prevention and treatment of injuries. CONCLUSION: According to the results found in this study, Matricaria recutita appeared to be a promising alternative for the treatment of oral mucositis. However, due to the great variability in the various types of intervention, more controlled double-blind randomized clinical studies are necessary to ensure the best protocol for treating oral mucositis.

Asunto(s)

Matricaria/química , Extractos Vegetales/uso terapéutico , Estomatitis/tratamiento farmacológico , Animales , Método Doble Ciego , Humanos , Resultado del Tratamiento

RESUMEN

The objective of this study was to evaluate the effect of different combinations of passionflower (Passiflora alata) and chamomile (Matricaria chamomile) on performance, egg quality, behavior and stress of quails during the rearing and laying phases. A total of 196 birds was distributed in randomized blocks, divided into four treatments (conventional feed: 125 mg of Matricaria chamomile + 375 mg of Passiflora alata/kg of feed; 250 mg of M. chamomile + 250 mg of P. alata/kg of feed; 375 mg of M. chamomile + 125 mg P. alata/kg of feed), with seven replications and seven birds per cage. The rearing period began at 28 days of age and lasted 14 days. At this stage were evaluated daily feed intake, daily weight gain, feed conversion, viability, time in tonic immobility (TIT), intensity of injury and heterophil/lymphocyte ratio (H:L). The laying period started when quails reached 42 days of age, in which feed intake, feed conversion, egg production and quality, viability, TIT, intensity of injury and H:L ratio. In the rearing period, the inclusion of the phytotherapics in the diets did not alter the performance, H:L ratio and the intensity of injury (P≥0,05), but the TIT decreased when adding 250 mg of each phytotherapic (P<0,05). In the laying period, the different combinations of chamomile and passionflower did not affect the performance and external quality of fresh eggs (P≥0,05). However, when 250 mg of each phytotherapic was added to the diets, there was a reduction in TIT, H:L ratio and intensity of injury in the head and body of the quails (P<0,05), indicating that the birds were less stressed. As for the internal quality of fresh eggs, there was an improvement in the Haugh unit and the percentages of yolk and albumen when adding 250 mg of each phytotherapic (P<0,05). We concluded that the inclusion of chamomile and passionflower in the diets does not alter the performance of the quails during the rearing and laying periods, does not influence the external...

---

O objetivo deste estudo foi avaliar o efeito de diferentes combinações de passiflora (Passiflora alata) e de camomila (Matricaria camomila) sobre o desempenho, qualidade de ovos, comportamento e estresse de codornas durante as fases de recria e de postura. Foram utilizadas 196 aves, distribuídas em blocos ao acaso, com quatro tratamentos (ração convencional; 125 mg de Matricaria chamomila + 375 mg de Passiflora alata/kg de ração; 250 mg de M. chamomila + 250 mg de P. alata/kg de ração; 375 mg de M. chamomila + 125 mg P. alata/kg de ração), com sete repetições e sete aves por parcela. A fase de recria iniciou-se aos 28 dias de idade das aves, durando 14 dias. Nesta fase foram avaliados consumo diário de ração, ganho diário de peso, conversão alimentar, viabilidade de criação, o tempo em imobilidade tônica (TIT), a intensidade de ferimentos e a relação entre heterófilos e linfócitos (H:L). A fase de postura teve início quando as aves atingiram 42 dias de idade, em que foram avaliados consumo de ração, conversão alimentar, produção e qualidade de ovos, viabilidade, TIT, intensidade de ferimentos e relação H:L. Na fase de recria a inclusão dos fitoterápicos às rações não alterou o desempenho, a relação H:L e as intensidades de lesões (P≥0,05), mas diminuiu o TIT quando da adição de 250 mg de cada fitoterápico (P<0,05). Na fase de postura as diferentes combinações de camomila e passiflora não afetaram o desempenho e a qualidade externa de ovos frescos (P≥0,05). No entanto, quando se adicionou 250 mg de cada extrato nas rações houve redução no TIT, na relação H:L e na intensidade de lesões na cabeça e corpo das aves (P<0,05), indicando que as aves estavam menos estressadas. Quanto à qualidade interna de ovos frescos, verificou-se melhora na unidade Haugh e nas porcentagens de gema e de albúmen quando da inclusão de 250 mg de cada fitoterápico (P<0,05). Conclui-se que a adição de camomila e de passiflora nas rações não altera o desempenho produtivo das aves nas...

Asunto(s)

Femenino , Animales , Coturnix/fisiología , Estrés Psicológico/dietoterapia , Matricaria/efectos adversos , Huevos/análisis , Passiflora/efectos adversos , Bienestar del Animal , Conducta Animal , Alimentación Animal